SUPERNK Trademark

Trademark Overview

On Monday, October 30, 2017, a trademark application was filed for SUPERNK with the United States Patent and Trademark Office. The USPTO has given the SUPERNK trademark a serial number of 87664459. The federal status of this trademark filing is PARTIAL SECTION 8 ACCEPTED as of Tuesday, August 5, 2025. This trademark is owned by NKMAX CO., LTD.. The SUPERNK trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Pharmaceutical Products categories with the following description:

[ Pharmaceutical preparations for the treatment of cells ]

[ Wholesale store services featuring cell therapy products; Retail store services featuring cell therapy products ]

Development of cell therapy products
supernk

General Information

Serial Number87664459
Word MarkSUPERNK
Filing DateMonday, October 30, 2017
Status704 - PARTIAL SECTION 8 ACCEPTED
Status DateTuesday, August 5, 2025
Registration Number5759513
Registration DateTuesday, May 21, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Services[ Pharmaceutical preparations for the treatment of cells ]
Pseudo MarkSUPER NK
Goods and Services[ Wholesale store services featuring cell therapy products; Retail store services featuring cell therapy products ]
Goods and ServicesDevelopment of cell therapy products

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, August 5, 2025
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 7, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, August 5, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNKGEN BIOTECH, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressGyeonggi-do 16419
KR
Party NameNKMAX CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 13605
KR
Party NameNKMAX CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 13605
KR

Trademark Events

Event DateEvent Description
Monday, February 12, 2018NON-FINAL ACTION WRITTEN
Thursday, November 2, 2017NEW APPLICATION ENTERED
Tuesday, November 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 9, 2018ASSIGNED TO EXAMINER
Monday, February 12, 2018NON-FINAL ACTION E-MAILED
Monday, February 12, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 11, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 7, 2018FINAL REFUSAL WRITTEN
Friday, September 7, 2018FINAL REFUSAL E-MAILED
Friday, September 7, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 20, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, February 26, 2019ASSIGNED TO LIE
Wednesday, February 27, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 27, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 1, 2019ACTION CONTINUING A FINAL - COMPLETED
Monday, April 1, 2019CONTINUATION OF FINAL REFUSAL E-MAILED
Monday, April 1, 2019NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Tuesday, April 9, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, April 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 10, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 11, 2019APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Saturday, April 13, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 21, 2019REGISTERED-SUPPLEMENTAL REGISTER
Friday, November 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 4, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 21, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, November 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 15, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 6, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, December 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 5, 2025REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Thursday, April 17, 2025TEAS SECTION 8 RECEIVED
Tuesday, July 29, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 5, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Related Keywords

supernk cell therapy products featuring store services retail development preparations treatment